Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Blood product safety

Nature Climate Change volume 3, pages 606–607 (2013)Cite this article

Subjects

To the Editor —

I read with interest Jan Semenza and Dragoslav Domanović's thoughtful discussion of the potential impact of climate change on the European blood supply1. The US Food and Drug Agency (FDA) collaborates with others to ensure blood product safety2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Semenza, J. C. & Domanović, D. Nature Clim. Change 3, 432–435 (2013).

    Article  Google Scholar 

  2. Davey, R. J. How FDA ensures the safety of blood products. FDA Voice (28 February 2012); available via http://go.nature.com/K1Wi6h

    Google Scholar 

  3. Schwartz, B. S., Parker, C. L., Hess, J. & Frumkin, H. Am. J. Public Health 101, 1560–1567 (2011).

    Article  Google Scholar 

  4. Karinkolos, M. et al. Lancet 381, 1323–1331 (2013).

    Article  Google Scholar 

  5. McDonough, J. E. N. Engl. J. Med. 368, 1269–1271 (2013).

    Article  CAS  Google Scholar 

  6. Hotez, P. J. & Gurwith, M. Int. J. Infect. Dis. 15, e611–e619 (2011).

    Article  Google Scholar 

  7. Hotez, P. J. PLoS Neglect. Trop. D. e256 (2008).

  8. Jordans, F. Boston Globe (27 February 2013); available via http://go.nature.com/NEjdAb

    Google Scholar 

  9. 36th Meeting of HHS Advisory Committee on Blood and Tissue Safety Availability Transcript 161, 195–196 (30 April 2009); available via http://go.nature.com/C6aFUj

  10. FDA Drug Shortages (FDA, 7 May 2013); available via http://go.nature.com/6NT5DT

Download references

Author information

Authors and Affiliations

  1. 203 Ravenwood Road, Exton, Pennsylvania, 19341, USA. Previously employed at the US Food and Drug Agency's Center for Biologics Evaluation and Research, Office of Blood Research and Review from November 2008 to April 2013,

    Mitchell Berger

Authors
  1. Mitchell Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitchell Berger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berger, M. Blood product safety. Nature Clim Change 3, 606–607 (2013). https://doi.org/10.1038/nclimate1928

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nclimate1928

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing